BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 5050309)

  • 1. [Experimental model of keratoconjunctival infections in the study of immunity against Shigella].
    Cefalù M; Puglisi C
    G Mal Infett Parassit; 1972 Apr; 24(4):281-9. PubMed ID: 5050309
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies of crossed immunity between different serotypes of dysentery bacilli and the keratoconjunctivitis-positive, lactoso-negative strain 47552 deprived of Shigella agglutinogen].
    Ciufeco C
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):389-94. PubMed ID: 4925072
    [No Abstract]   [Full Text] [Related]  

  • 3. An experimental study of postvaccination and postinfectious immunity to dysenteria in guinea-pigs.
    Manolov DG; Kosturkov GB
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(3):347-52. PubMed ID: 5629951
    [No Abstract]   [Full Text] [Related]  

  • 4. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity.
    Meitert T
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of buprenorphine on immunogenicity and protective efficacy in the guinea pig keratoconjunctivitis model (Sereny test).
    Hanson CE; Ruble GR; Essiet I; Hartman AB
    Comp Med; 2001 Jun; 51(3):224-9. PubMed ID: 11924776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental keratoconjunctivitis (Sereny) assay.
    Kopecko DJ
    Methods Enzymol; 1994; 235():39-47. PubMed ID: 8057912
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunity to keratoconjunctivitis shigellosa in rabbits after oral immunization with Shigella sonnei free endotoxin.
    Kowalewska D; Mulczyk M
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):99-102. PubMed ID: 4613143
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunity to experimental mouse shigellosis.
    Rauss K; Kétyi I
    Arch Immunol Ther Exp (Warsz); 1968; 16(3):491-6. PubMed ID: 5666686
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and administration of live Shigella vaccines.
    Pencu E
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):231-50. PubMed ID: 6443689
    [No Abstract]   [Full Text] [Related]  

  • 10. A study on experimental keratoconjunctivitis shigellosa.
    Okamoto M
    Kitasato Arch Exp Med; 1980 Dec; 53(3-4):81-96. PubMed ID: 7035740
    [No Abstract]   [Full Text] [Related]  

  • 11. Live dysentery vaccine "Vadizen" (T32-Istrati) immunogenicity against Shigella-like challenge in animals.
    Ciudin L; Meitert T; Pencu E; Gheorghe G; Tonciu M; Mihai I; Manase R
    Arch Roum Pathol Exp Microbiol; 1986; 45(3-4):247-56. PubMed ID: 3300598
    [No Abstract]   [Full Text] [Related]  

  • 12. EXPERIMENTAL KERATOCONJUNCTIVITIS SHIGELLOSIS IN GUINEA PIGS. I. IMMUNE PHENOMENON AND ANTIBODY FORMATION.
    LIN FC; YANG TL; YEH SH
    Chin Med J; 1964 Jul; 83():454-62. PubMed ID: 14191218
    [No Abstract]   [Full Text] [Related]  

  • 13. [Modern concepts of immunity in bacterial dysentery (a review)].
    Pokrovskiĭ VI; Litinskiĭ IuI; Godovannyĭ BA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Sep; (9):15-21. PubMed ID: 4613079
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacteriological and epidemiological approach to prophylaxy for enteric infection. IV. Experimental bladder infection of Shigella.
    Anzai H; Kubota Y; Okamoto M; Sekizuka S; Nakamura T
    Kitasato Arch Exp Med; 1971 Dec; 44(3):155-66. PubMed ID: 4949632
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study on cross immunity in Shigellae following local immunisation with living non-infectious agents].
    Istrati G; Meitert T; Ciufecu C; Sulea I
    Zentralbl Bakteriol Orig; 1970; 215(1):73-6. PubMed ID: 4922615
    [No Abstract]   [Full Text] [Related]  

  • 16. The anti-infectious immunogenic potency of some kerato-conjunctivitis - positive enteropathogenic strains lacking Shigella agglutinogens.
    Ciufecu C
    Arch Roum Pathol Exp Microbiol; 1974; 33(3-4):241-60. PubMed ID: 4467830
    [No Abstract]   [Full Text] [Related]  

  • 17. [Features of the formation of antibodies to heterologous antigens in experimental Shigella infection in guinea pigs and mice].
    Borisov VA
    Mikrobiol Zh (1978); 1989; 51(3):52-6. PubMed ID: 2796788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and pathogenicity of provisional serovar 1621-54 of "Shigella" from imported cynomolgus monkeys.
    Takasaka M; Kono A; Kono M; Nakamura A; Sakakibara I; Honjo S
    Jpn J Med Sci Biol; 1983 Feb; 36(1):27-37. PubMed ID: 6865099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on Shigella vaccines.
    Ashkenazi S; Cohen D
    Isr J Med Sci; 1994; 30(5-6):495-7. PubMed ID: 8034510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The keratoconjunctivitis test].
    Ciufecu C
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):7-27. PubMed ID: 4936246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.